Anthony Ivetac is the Executive Director and Head of Computational Sciences at Iambic Therapeutics, a position held since 2024. Previously, Anthony served as a Senior Principal Scientist in Computational Chemistry at Mirati Therapeutics from 2019 to 2024 and held various roles, including Staff Scientist and Senior Scientist in Computational Chemistry at Takeda San Diego, Inc. from 2010 to 2018. Anthony's academic background includes a Ph.D. in Computational Biochemistry from the University of Oxford and an M.Sc. in Computer Science from University College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices